Core Insights - The company reported a revenue of 2,564,308,490.01 yuan for the third quarter of 2025, representing a year-on-year growth of 13.48% [2] - The net profit attributable to shareholders of the listed company reached 72,896,120.41 yuan, showing a significant year-on-year increase of 294.98% [2] Financial Performance - Revenue for Q3 2025: 2,564.31 million yuan, up 13.48% year-on-year [2] - Net profit for Q3 2025: 72.90 million yuan, up 294.98% year-on-year [2]

| | | 漱玉平民大药房连锁股份有限公司 关于 2025 年前三季度计提资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、本次计提资产减值准备情况概述 根据《企业会计准则》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市 公司自律监管指引第 2 号——创业板上市公司规范运作》等相关规定的要求，为了更加真 实、准确、客观地反映公司的财务状况、资产价值及经营成果，本着谨慎性原则，漱玉平 民大药房连锁股份有限公司（以下简称"公司"、"本公司"）根据相关政策要求，对公司的 各类资产进行了全面检查和减值测试，并对公司截至 2025 年 9 月 30 日合并报表范围内的 有关资产计提相应的减值准备。2025 年前三季度拟计提减值准备 30,340,542.39 元，其中 信用减值损失 21,089,088.76 元，资产减值损失 9,251,453.63 元。 具体情况如下： | 类别 | 项目 | 2025 年前三季度计提金额（元） | | --- | --- | --- | | 信用减值损失 | 应收账款坏账损失 | 5,148,00 ...

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-094 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于追加 2025 年度日常关联交易预计额度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于 2025 年 4 月 27 日召开第四 届董事会第五次会议及第四届监事会第三次会议，分别审议通过了《关于公司<2025 年度日 常关联交易预计>的议案》，根据公司业务发展及日常经营需要，2025 年度拟与关联方发生 商品采购、出售商品、接受劳务、手续费、服务费、配送费、仓储费、房屋租赁等日常关 联交易，预计 2025 年度将与关联方发生的日常关联交易总额不超过人民币 10,148.00 万元。 具体内容详见公司于 2025 年 4 月 29 日披露于巨潮资讯网（www.cninfo.com.cn）《关于 2025 年度日常关联交易预计的公告》 ...

| | | 漱玉平民大药房连锁股份有限公司 第四届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、监事会会议召开情况 漱玉平民大药房连锁股份有限公司（以下简称"公司"）第四届监事会第七次会议于 2025 年 10 月 27 日在公司会议室以现场表决的方式召开。会议通知及会议资料已于 2025 年 10 月 23 日以书面、电子邮件等方式送达各位监事。会议由监事会主席孟鹏女士召集并主持， 会议应到监事 3 人，实到监事 3 人，董事会秘书列席了本次会议。本次会议召开符合《中 华人民共和国公司法》及《公司章程》等有关规定。 二、监事会会议审议情况 1、审议通过《关于公司<2025 年第三季度报告>的议案》 经审议，监事会认为：公司《2025 年第三季度报告》编制和审议程序符合相关法律法 规、中国证券监督管理委员会和深圳证券交易所的相关规定，报告内容真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏。 表决结果：同意 3 票；反对 0 票；弃权 0 票。 具体情况详见公司同日披露于巨潮资讯网（www.cninfo.com.cn） ...

一、董事会会议召开情况 漱玉平民大药房连锁股份有限公司（以下简称"公司"）第四届董事会第十二次会议于 2025 年 10 月 27 日在公司会议室以现场结合通讯表决的方式召开。会议通知已于 2025 年 10 月 23 日以书面、电子邮件等方式送达各位董事，会议应到董事 9 人，实到董事 9 人，其 中董事秦光霞女士、杨策先生，独立董事李文明先生以通讯表决方式出席。公司监事和高 级管理人员列席了本次会议。会议由公司董事长李文杰先生主持，本次会议召开符合《中 华人民共和国公司法》及《漱玉平民大药房连锁股份有限公司章程》等有关规定。 二、董事会会议审议情况 1、审议通过《关于公司<2025 年第三季度报告>的议案》 经审议，董事会认为：公司《2025 年第三季度报告》编制和审议程序符合相关法律法 规、中国证券监督管理委员会和深圳证券交易所的相关规定，报告内容真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏。 公司审计委员会已审议通过该议案。 | | | 漱玉平民大药房连锁股份有限公司 第四届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者 ...

追加 2025 年度日常关联交易预计额度的核查意见 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为漱玉 平民大药房连锁股份有限公司（以下简称"漱玉平民"或"公司"）向不特定对 象发行可转换公司债券的保荐机构，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关法律法规的要求，现对漱玉平民追加 2025 年度日常 关联交易预计额度进行了核查，并发表如下意见： 一、日常关联交易基本情况 （一）日常关联交易概述 漱玉平民于 2025 年 4 月 27 日召开第四届董事会第五次会议及第四届监事会 第三次会议，分别审议通过了《关于公司<2025 年度日常关联交易预计>的议案》， 根据公司业务发展及日常经营需要，2025 年度拟与关联方发生商品采购、出售 商品、接受劳务、手续费、服务费、配送费、仓储费、房屋租赁等日常关联交易， 预计 2025 年度将与关联方发生的日常关联交易总额不超过人民币 10,148.00 万 元。具体内容详见公司于 20 ...

Core Insights - The company reported a revenue of 7.446 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 5.19% [1] - The net profit attributable to shareholders reached 109 million yuan, showing a significant year-on-year increase of 927.37% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 9.4046 million yuan, reflecting a year-on-year growth of 160.23% [1] - The basic earnings per share stood at 0.27 yuan [1]

Group 1 - The core viewpoint of the news is that Shuyupingmin reported significant growth in its third-quarter performance for 2025, with revenue and net profit showing substantial year-on-year increases [1] - For the first three quarters of 2025, the company's revenue reached approximately 7.446 billion yuan, representing a year-on-year increase of 5.19% [1] - The net profit attributable to shareholders was approximately 109 million yuan, reflecting a remarkable year-on-year increase of 927.37% [1] - Basic earnings per share were reported at 0.27 yuan, which is a 1000% increase compared to the previous year [1] Group 2 - As of the report date, the market capitalization of Shuyupingmin is 4.6 billion yuan [2] - The A-share market has recently surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology leading the market's transformation [2]

Group 1 - The core viewpoint of the article highlights the financial performance of the company in the third quarter, with revenue reaching 2.564 billion yuan, representing a year-on-year increase of 13.48% [1] - The net profit for the third quarter was 72.8961 million yuan, showing a significant year-on-year growth of 294.98% [1] - For the first three quarters, the company's revenue totaled 7.446 billion yuan, reflecting a year-on-year increase of 5.19% [1] Group 2 - The net profit for the first three quarters amounted to 109.61 million yuan, which is a remarkable year-on-year increase of 927.37% [1]

Financial Performance - The company's revenue for Q3 2025 reached ¥2,564,308,490.01, representing a year-on-year increase of 13.48%[4] - Net profit attributable to shareholders was ¥72,896,120.41, a significant increase of 294.98% compared to the same period last year[4] - The basic earnings per share rose to ¥0.18, marking a 300.00% increase year-on-year[4] - In the first three quarters of 2025, the company achieved operating revenue of CNY 744.55 million, a year-on-year increase of 5.19%, and a net profit attributable to shareholders of CNY 109.15 million, a significant increase of 927.37%[19] - The net profit excluding non-recurring gains and losses reached CNY 9.40 million, up 160.23% year-on-year[19] - Net profit for the period was ¥100,856,450.25, a significant recovery from a net loss of ¥28,498,927.90 in the previous year[35] - Operating profit improved to ¥147,147,406.05 compared to a loss of ¥1,623,384.50 in the same period last year[33] - Basic and diluted earnings per share were both ¥0.27, recovering from a loss of ¥0.03 per share in the previous year[36] - The company reported a total profit of ¥135,578,418.79, recovering from a loss of ¥16,285,037.28 in the same period last year[35] Assets and Liabilities - The total assets of the company increased to ¥10,018,705,946.99, reflecting an 8.04% growth from the previous year[7] - The company's goodwill increased by 30.21% to ¥2,281,932,857.80, primarily due to acquisitions during the reporting period[12] - The company’s liabilities increased, with accounts payable rising by 51.48% to ¥1,751,998,626.26, indicating higher purchase obligations[12] - The total current liabilities rose to ¥6,189,778,365.92 from ¥5,362,410,305.97, marking an increase of approximately 15.4%[30] - The total non-current liabilities decreased to ¥1,598,619,358.35 from ¥1,785,712,083.01, reflecting a decline of about 10.5%[31] - The company's total equity increased to ¥2,230,308,222.72 from ¥2,125,070,292.99, indicating a growth of approximately 4.9%[31] Cash Flow and Investments - The company reported a net cash flow from operating activities of ¥624,163,644.07, which is a 160.56% increase year-to-date[4] - Cash flow from operating activities generated a net inflow of ¥624,163,644.07, up from ¥239,543,017.67 in the prior year[38] - Investment activities resulted in a net cash outflow of ¥728,805,481.89, worsening from a smaller outflow of ¥21,901,815.19 in the previous year[38] Operational Metrics - The overall gross margin declined by 1.35% due to changes in industry policies, regulatory environments, and consumer behavior[20] - The company optimized its store network, resulting in a year-on-year improvement in the expense-to-sales ratio by 1.45%[20] - As of September 30, 2025, the company operated a total of 8,617 stores across several provinces, with 4,972 being direct-operated stores[21] - The company has a steady expansion strategy, having opened 3 new stores and acquired 754 stores while closing 223 stores in the reporting period[21] - A total of 1,939 convertible bonds were converted into 12,832 shares of stock by the end of September 2025[22] - The company continues to focus on a direct chain marketing model and regional deep cultivation strategies to enhance profitability[21] Market and Product Development - The company is diversifying its product offerings to include health products, healthcare items, medical devices, and beauty products to meet consumer demand[21] - The company reported a revenue increase of 15% year-over-year, reaching 1.2 billion RMB in Q3 2025[41] - User data showed a growth of 20% in active customers, totaling 5 million users by the end of Q3 2025[41] - New product launches contributed to a 25% increase in sales in the health supplement category[41] - The company is investing 50 million RMB in R&D for new technology aimed at improving customer experience[41] - Market expansion efforts have led to the opening of 30 new stores in tier-2 cities, increasing the total store count to 200[41] - The company is exploring potential acquisitions to enhance its product offerings and market presence[41] - A new marketing strategy is projected to increase brand awareness by 15% in the next quarter[41] - The gross margin improved to 35%, up from 32% in the previous quarter[41] - The company plans to allocate 10% of its revenue towards sustainability initiatives in the upcoming fiscal year[41] Other Financial Metrics - The company confirmed a fair value change gain of ¥127,905,105.59, a dramatic increase of 196,527.69% compared to the previous period[12] - The company's cash and cash equivalents decreased to ¥1,306,337,761.38 from ¥1,404,760,376.62, representing a decline of approximately 7.0%[27] - Inventory levels increased to ¥2,099,057,605.58 from ¥1,891,086,015.63, showing a rise of about 11.0%[28] - The company incurred a tax expense of ¥34,721,968.54, compared to ¥12,213,890.62 in the previous year, indicating a rise in tax obligations[35] - Total operating costs increased to ¥7,426,697,847.88 from ¥7,068,782,768.84, representing a rise of approximately 5.06% year-over-year[33] - The company decided not to adjust the conversion price of the "Shuyu Convertible Bonds" despite triggering conditions for downward adjustment, maintaining the price at ¥12.71 per share[25] - The company will reassess the conversion price adjustment rights if the conditions are triggered again after December 9, 2025[25]